Identification and characterization of nucleophosmin/B23/numatrin which binds the anti-oncogenic transcription factor IRF-1 and manifests oncogenic activity

No abstract is available for this paper.

• Publication year

  1997

• Venue

  Oncogene

• Publication date

  1997-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/sj.onc.1201286PMID 9315094
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Identification of the lysyl oxidase gene as target of the antioncogenic transcription factor, IRF-1, and its possible role in tumor suppression.

  1996cited by this paper
• Cooperation of the tumour suppressors IRF-1 and p53 in response to DNA damage

  1996cited by this paper
• An IRF-1-dependent pathway of DNA damage-induced apoptosis in mitogen-activated T lymphocytes

  1995cited by this paper
• Possible involvement of the transcription factor ISGF3 gamma in virus-induced expression of the IFN-beta gene.

  1995cited by this paper
• Requirement for transcription factor IRF-1 in NO synthase induction in macrophages.

  1994cited by this paper
• Accelerated exon skipping of IRF-1 mRNA in human myelodysplasia/leukemia; a possible mechanism of tumor suppressor inactivation.

  1994cited by this paper
• Suppression of c-myc or fosB-induced cell transformation by the transcription factor IRF-1.

  1994cited by this paper
• Involvement of the IRF-1 transcription factor in antiviral responses to interferons.

  1994cited by this paper
• Human cancer cell lines express a negative transcriptional regulator of the interferon regulatory factor family of DNA binding proteins.

  1994cited by this paper
• Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1.

  1994cited by this paper
• Structure and regulation of the human interferon regulatory factor 1 (IRF-1) and IRF-2 genes: implications for a gene network in the interferon system

  1994cited by this paper
• Functional dissection of p56lck, a protein tyrosine kinase which mediates interleukin-2-induced activation of the c-fos gene

  1994cited by this paper
• Purification of glutathione S-transferase fusion proteins as a non-degraded form by using a protease-negative E. coli strain, AD202.

  1994cited by this paper
• mdm2 expression is induced by wild type p53 activity.

  1993cited by this paper
• Interferon regulatory factor 1 (IRF-1) mediates cell growth inhibition by transactivation of downstream target genes.

  1993cited by this paper
• Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development.

  1993cited by this paper
• Deletion of IRF-1, mapping to chromosome 5q31.1, in human leukemia and preleukemic myelodysplasia

  1993cited by this paper
• Anti-oncogenic and oncogenic potentials of interferon regulatory factors-1 and -2

  1993cited by this paper
• The p53-mdm-2 autoregulatory feedback loop.

  1993cited by this paper
• p53 function and dysfunction.

  1992cited by this paper
• Amplification of a gene encoding a p53-associated protein in human sarcomas

  1992cited by this paper
• Tumor suppressor genes.

  1991cited by this paper
• Identification of cellular proteins that can interact specifically with the T/E1A-binding region of the retinoblastoma gene product.

  1991cited by this paper
• Absence of the type I IFN system in EC cells: Transcriptional activator (IRF-1) and repressor (IRF-2) genes are developmentally regulated

  1990cited by this paper
• A nuclear factor for IL‐6 expression (NF‐IL6) is a member of a C/EBP family.

  1990cited by this paper
• Structurally similar but functionally distinct factors, IRF-1 and IRF-2, bind to the same regulatory elements of IFN and IFN-inducible genes.

  1989cited by this paper
• Major nucleolar proteins shuttle between nucleus and cytoplasm.

  1989cited by this paper
• Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.

  1989cited by this paper
• Regulated expression of a gene encoding a nuclear factor, IRF-1, that specifically binds to IFN-beta gene regulatory elements.

  1988cited by this paper
• The nuclear matrix protein, numatrin (B23), is associated with growth factor-induced mitogenesis in Swiss 3T3 fibroblasts and with T lymphocyte proliferation stimulated by lectins and anti-T cell antigen receptor antibody

  1988cited by this paper
• Improved mammalian vectors for high expression of G418 resistance.

  1987cited by this paper
• Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.

  1986cited by this paper
• Isolation of microgram quantities of proteins from polyacrylamide gels for amino acid sequence analysis.

  1983cited by this paper
• Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei.

  1983cited by this paper
• Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis.

  1977cited by this paper
• Human chronic myelogenous leukemia cell-line with positive Philadelphia chromosome.

  1975cited by this paper
• Early alterations in amino acid pools and protein synthesis of diploid fibroblasts stimulated to synthesize DNA by addition of serum

  1969cited by this paper

• Knockdown of dual-specificity phosphatase 3 drives differentiation and polarization of myeloid leukemia cells into macrophages with reduced proliferative and DNA repair fitness.

  2025cites this paper
• Nucleophosmin 1 promotes mucosal immunity by supporting mitochondrial oxidative phosphorylation and ILC3 activity

  2024cites this paper
• NPM1 inhibits tumoral antigen presentation to promote immune evasion and tumor progression

  2024cites this paper
• Host Factor Nucleophosmin 1 (NPM1/B23) Exerts Antiviral Effects against Chikungunya Virus by Its Interaction with Viral Nonstructural Protein 3

  2023cites this paper
• NPM promotes hepatotoxin-induced fibrosis by inhibiting ROS-induced apoptosis of hepatic stellate cells and upregulating lncMIAT-induced TGF-β2

  2023cites this paper
• Nucleophosmin Plays a Role in Repairing DNA Damage and Is a Target for Cancer Treatment

  2023cites this paper
• The Role of Nucleophosmin 1 (NPM1) Mutation in the Diagnosis and Management of Myeloid Neoplasms

  2022cites this paper
• Targeting CK2 mediated signaling to impair/tackle SARS-CoV-2 infection: a computational biology approach

  2021cites this paper
• Histone Chaperone Nucleophosmin Regulates Transcription of Key Genes Involved in Oral Tumorigenesis

  2021cites this paper
• CIGB-300 synthetic peptide, an antagonist of CK2 kinase activity, as a treatment for Covid-19. A computational biology approach

  2021cites this paper
• Histone chaperone Nucleophosmin regulates transcription of key genes involved in oral tumorigenesis

  2019cites this paper
• Oncogene c‐fos and mutant R175H p53 regulate expression of Nucleophosmin implicating cancer manifestation

  2018cites this paper
• NPM1 alternative transcripts are upregulated in acute myeloid and lymphoblastic leukemia and their expression level affects patient outcome

  2018cites this paper
• Interferon regulatory factor 1 inactivation in human cancer

  2018cites this paper
• Selective regulation of type II interferon‐inducible genes by NPM1/nucleophosmin

  2018cites this paper
• A polypeptide from the junction region sequence of EWS-FLI1 inhibits Ewing’s sarcoma cells, interacts with the EWS-FLI1 and partner proteins

  2017cites this paper
• Downregulation of nucleophosmin expression inhibited proliferation and induced apoptosis in salivary gland adenoid cystic carcinoma

  2017cites this paper
• 7 Centrosome Abnormality and Human Lung Cancer

  2017cites this paper
• Involvement of the specific nucleolar protein SURF6 in regulation of proliferation and ribosome biogenesis in mouse NIH/3T3 fibroblasts

  2017cites this paper
• Simultaneous detection of mutations and copy number variation of NPM1 in the acute myeloid leukemia using multiplex ligation-dependent probe amplification.

  2016cites this paper
• Friends or Foes

  2016cites this paper
• Roles of Interferon Regulatory Factors in Chronic Myeloid Leukemia.

  2016cites this paper
• Whole-exome sequencing reveals potential molecular predictors of relapse after discontinuation of the targeted therapy in chronic myeloid leukemia patients

  2016cites this paper
• MicroRNA-23a downregulates the expression of interferon regulatory factor-1 in hepatocellular carcinoma cells

  2016cites this paper
• Caractérisation des transcrits antisens chez les rétrovirus HTLV et étude comparative des fonctions des protéines traduites à partir de ces transcrits antisens

  2015cites this paper
• A novel mechanism of post-translational modulation of HMGA functions by the histone chaperone nucleophosmin

  2015cites this paper
• Understanding the relationship between IRF-1 and the transcriptional repressor ZNF350

  2015cites this paper
• Emerging roles of nucleolar and ribosomal proteins in cancer, development, and aging

  2015cites this paper
• Étude du rôle du facteur de transcription UBF dans la régulation de la transcription ribosomale "in vivo"

  2015influential citation
• Time-Gated Luminescence Detection for High-Throughput Screening of Protein Interaction and Inhibitions

  2015cites this paper
• Proteomic characterisation of chronic lymphocytic leukaemia cells treated with rituximab

  2014cites this paper
• Interferon regulatory factor-1 (IRF-1) interacts with regulated in development and DNA damage response 2 (REDD2) in the cytoplasm of mouse bone marrow cells.

  2014cites this paper
• Mammalian Ribosome Nuclear Export Chaperone for the Nucleophosmin Serves as a Rate-Limiting

  2014cites this paper
• Investigation of Epstein-Barr Virus-Host Interactions during Latent and Lytic Infection

  2014cites this paper
• ARF Impedes NPM/B23 Shuttling in an

  2014cites this paper
• Genetic and Epigenetic Regulation of Interferon Regulatory Factor Expression: Implications in Human Malignancies

  2013cites this paper
• A role for PVRL4-driven cell–cell interactions in tumorigenesis

  2013cites this paper
• Proteomic changes induced by podophyllotoxin in human cervical carcinoma HeLa cells.

  2013cites this paper
• Identification of Converging Pathways in the pathogenesis of NPM-RARA Variant Acute Promyelocytic Leukemia

  2013cites this paper
• Role of C-terminal phosphorylation in the regulation of the tumour suppressor IRF-1

  2013influential citation
• A role for PVRL 4-driven cell-cell interactions in tumorigenesis Citation

  2013cites this paper
• miR-23a Targets Interferon Regulatory Factor 1 and Modulates Cellular Proliferation and Paclitaxel-Induced Apoptosis in Gastric Adenocarcinoma Cells

  2013cites this paper
• Mutations in the Nucleolar Phosphoprotein, Nucleophosmin, Promote the Expression of the Oncogenic Transcription Factor MEF/ELF4 in Leukemia Cells and Potentiates Transformation*

  2013cites this paper
• Functional studies of MP62 during male chromatin decondensation in sea urchins

  2013cites this paper
• Proteomic analysis of proteins responsible for the development of doxorubicin resistance in human uterine cancer cells.

  2012cites this paper
• The IRF family of transcription factors

  2012cites this paper
• Function and mechanism by which interferon regulatory factor-1 inhibits oncogenesis

  2012influential citation
• Erythroid differentiation‐associated gene interacts with NPM1 (nucleophosmin/B23) and increases its protein stability, resisting cell apoptosis

  2012cites this paper
• Chemical genetic manipulation of interferon regulatory factor 1 (IRF-1) using synthetic biology

  2012cites this paper
• DIFFERENTIAL SENSITIVITY TO UNRELATED ALK INHIBITORS

  2012cites this paper
• Centrosome Abnormality and Human Lung Cancer

  2012cites this paper
• Akt2 and nucleophosmin/B23 function as an oncogenic unit in human lung cancer cells.

  2011cites this paper
• Mutation of cysteine 21 inhibits nucleophosmin/B23 oligomerization and chaperone activity.

  2011cites this paper
• A Multiprotein Binding Interface in an Intrinsically Disordered Region of the Tumor Suppressor Protein Interferon Regulatory Factor-1*

  2011cites this paper
• Knockdown of NPM1 by RNA Interference Inhibits Cells Proliferation and Induces Apoptosis in Leukemic Cell Line

  2011cites this paper
• Protein kinase C as a cancer marker and target for anticancer therapy

  2011cites this paper
• Detection of nucleophosmin 1 mutations by quantitative real-time polymerase chain reaction versus capillary electrophoresis: a comparative study.

  2011cites this paper
• Development of an intrabody capable of activating interferon regulatory factor-1 [IRF-1] and identification of IRF-1-binding peptide motifs

  2011influential citation
• Quantitative nucleolar proteomics reveals nuclear re-organization during stress- induced senescence in mouse fibroblast

  2011cites this paper
• The Multifunctional Nucleolar Protein Nucleophosmin/NPM/B23 and the Nucleoplasmin Family of Proteins

  2011influential citation
• Interactomics identifies novel regulators of the IRF-1 tumour suppressor protein

  2011influential citation
• The Role of Interferon Regulatory Factor-1 (IRF1) in Overcoming Antiestrogen Resistance in the Treatment of Breast Cancer

  2011cites this paper
• Identification of stem cell factors Novel protein-protein interactions and their functions

  2010cites this paper
• Proteomic profile regulated by the anticancer peptide CIGB-300 in non-small cell lung cancer (NSCLC) cells.

  2010cites this paper
• Nucleophosmin/B23: A Multifunctional Regulator that Determines the Fate of CCN2 mRNA

  2010cites this paper
• Rational drug design: A GAGE derived peptide kills tumor cells

  2010cites this paper
• Over Expression of Nucleophosmin and Nucleolin Contributes to the Suboptimal Activation of a G2/M Checkpoint in Ataxia Telangiectasia Fibroblasts.

  2010cites this paper
• Core transcription factors, Oct4, Sox2 and Nanog, individually form complexes with nucleophosmin (Npm1) to control embryonic stem (ES) cell fate determination

  2010cites this paper
• Regulation of immunity and oncogenesis by the IRF transcription factor family

  2010cites this paper
• Tumor suppressor HLJ1 binds and functionally alters nucleophosmin via activating enhancer binding protein 2alpha complex formation.

  2010cites this paper
• NPM phosphorylation stimulates Cdk1, overrides G2/M checkpoint and increases leukemic blasts in mice.

  2010cites this paper
• The ratio of SRPK1/SRPK1a regulates erythroid differentiation in K562 leukaemic cells.

  2010cites this paper
• Translationally controlled tumor protein interacts with nucleophosmin during mitosis in ES cells

  2010cites this paper
• To reactivate or not to reactivate : Control of KSHV lytic replication is essential for apoptosis in response to p53 restoration

  2010influential citation
• Tumor and Stem Cell Biology Cancer Research Tumor Suppressor HLJ 1 Binds and Functionally Alters Nucleophosmin via Activating Enhancer Binding Protein 2 α Complex Formation

  2010cites this paper
• NPM1/B23: A Multifunctional Chaperone in Ribosome Biogenesis and Chromatin Remodeling

  2010cites this paper
• XBP1, Unfolded Protein Response, and Endocrine Responsiveness

  2009cites this paper
• Nucleophosmin Blocks Mitochondrial Localization of p53 and Apoptosis*

  2009cites this paper
• Role of nucleophosmin in acute myeloid leukemia

  2009cites this paper
• GAGE, an Antiapoptotic Protein Binds and Modulates the Expression of Nucleophosmin/B23 and Interferon Regulatory Factor 1

  2009cites this paper
• Gene network signaling in hormone responsiveness modifies apoptosis and autophagy in breast cancer cells.

  2009cites this paper
• Nucleophosmin redistribution following heat shock: a role in heat-induced radiosensitization.

  2009cites this paper
• Nucleophosmin protein expression level, but not threonine 198 phosphorylation, is essential in growth and proliferation

  2009cites this paper
• Interaction with checkpoint kinase 1 modulates the recruitment of nucleophosmin to chromatin.

  2009cites this paper
• The challenge of risk stratification in acute myeloid leukemia with normal karyotype.

  2008cites this paper
• A new DNA-based test for detection of nucleophosmin exon 12 mutations by capillary electrophoresis.

  2008cites this paper
• Involvement of PKC in TPA-potentiated apoptosis induction during hemin-mediated erythroid differentiation in K562 cells

  2008cites this paper
• The IRF family transcription factors in immunity and oncogenesis.

  2008cites this paper
• NSC348884, a nucleophosmin inhibitor disrupts oligomer formation and induces apoptosis in human cancer cells

  2008cites this paper
• Analysis of the Differential Host Cell Nuclear Proteome Induced by Attenuated and Virulent Hemorrhagic Arenavirus Infection

  2008cites this paper
• Association of nucleophosmin/B23 with bladder cancer recurrence based on immunohistochemical assessment in clinical samples

  2008cites this paper
• Nucleophosmin/B23 Negatively Regulates GCN5-dependent Histone Acetylation and Transactivation*

  2008cites this paper
• Sperm nucleosomes disassembly is a requirement for histones proteolysis during male pronucleus formation

  2008cites this paper
• Nucleophosmin Serves as a Rate-Limiting Nuclear Export Chaperone for the Mammalian Ribosome

  2008cites this paper
• Interferon regulatory factor family of transcription factors and regulation of oncogenesis

  2008cites this paper
• Entwicklung und Anwendung neuer Analyseverfahren zur Differenzierung muriner embryonaler Stammzellen

  2008cites this paper
• Investigating the molecular basic of AMKL and MDS

  2008cites this paper
• Non-redundant roles of E(spl) proteins during Drosophila neurogenesis

  2008cites this paper
• The structure and functions of NPM1/Nucleophsmin/B23, a multifunctional nucleolar acidic protein.

  2007cites this paper
• Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters

  2007influential citation